You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
McKesson
McKinsey
AstraZeneca
Merck

Last Updated: February 16, 2020

DrugPatentWatch Database Preview

XANAX XR Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

When do Xanax Xr patents expire, and when can generic versions of Xanax Xr launch?

Xanax Xr is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in XANAX XR is alprazolam. There are fifteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the alprazolam profile page.

US ANDA Litigation and Generic Entry Outlook for Xanax Xr

A generic version of XANAX XR was approved as alprazolam by DAVA INTL INC on October 19th, 1993.

  Start Trial

Drug patent expirations by year for XANAX XR
Drug Prices for XANAX XR

See drug prices for XANAX XR

Pharmacology for XANAX XR
Drug ClassBenzodiazepine
Synonyms for XANAX XR
(Z)-8-chloro-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine
08H
12-chloro-3-methyl-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0;{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene
28981-97-7
3u5j
4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-
4H-(1,2,4)Triazolo(4,3-alpha)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-1-methyl-6-phenyl-
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine,8-chloro-1-methyl-6-phenyl-
4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-
51339-48-1
8-chloranyl-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
8-chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-a] [1,4] benzodiazepine
8-chloro-1-methyl-6-phenyl-4H-s-triazolo [4,3-a][1,4] benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo(4,3-alpha)(1,4)benzodiazepine
8-Chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine
8-chloro-6-phenyl-1-methyl-4H-s-triazolo-[4,3-a][1,4]benzodiazepine
981A977
A819702
AC-18721
AC1L1CYL
ACN-036616
AKOS005066050
Alcelam
Algad
Alpaz
Alplax
Alpram
Alprax
alprazolam
Alprazolam (JP17/USP/INN)
Alprazolam [USAN:INN:BAN:JAN]
Alprazolam [USAN:USP:INN:BAN:JAN]
Alprazolam 0.1 mg/ml in Methanol
Alprazolam 1.0 mg/ml in Methanol
Alprazolam extended release tablets
Alprazolam intensol
Alprazolam solution, 1 mg/mL in methanol, analytical standard, for drug analysis
Alprazolam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Alprazolam, European Pharmacopoeia (EP) Reference Standard
Alprazolamum
Alprazolamum [INN-Latin]
Alprazolan
Alpronax
Alprox
Alviz
Alzam
Alzolam
Alzon
Anpress
AP-1002
API0001427
Apo-Alpraz
AZ-002
Azor
BBL028160
BC226242
BDBM50001728
Bestrol
BIDD:GT0475
BIDD:PXR0150
BRD-K32398298-001-01-4
BRN 1223125
C06817
CAS-28981-97-7
Cassadan
CCG-100855
CHEBI:2611
CHEMBL661
Constan
CPD000149316
D 65MT
D-65MT
D00225
DB00404
DEA No. 2882
DSSTox_CID_2577
DSSTox_GSID_22577
DSSTox_RID_76639
DTXSID4022577
EINECS 249-349-2
Esparon
Frontal
FT-0658560
Gen-Alprazolan
GTPL7111
Helex
HMS2051A10
HMS3393A10
HSDB 7207
I14-7472
Intensol
Ksalol
LS-156344
MCULE-1215564244
Mialin
MLS000559000
MLS000759485
MLS001423979
NC00105
NCGC00159466-02
NCGC00159466-03
Neurol
Niravam
Novo-Alprazol
NSC-760140
NSC760140
Nu-Alpraz
Panistat
Panix
Pharmakon1600-01502395
Pharnax
Prazam
Prazolan
Prinox
Ralozam
Relaxol
Restyl
SAM001246696
SCHEMBL8398
SMR000149316
Solanax
Staccato-alprazolam
STK590494
Tafil
Tafil D
Tensivan
TGAR01P
Tox21_111692
Tranax
Trankimazin
Tranquinal
Tricalma
Tus 1
TUS-1
U 31889
U-31,889
U-31889
UNII-YU55MQ3IZY
Unilan
Valeans
VREFGVBLTWBCJP-UHFFFAOYSA-N
W-107015
Xanagis
Xanax
Xanax (TN)
Xanax TS
Xanolam
Xanor
YU55MQ3IZY
Zacetin
Zanapam
Zaxan
ZB000199
Zenax
ZINC903
Zolam
Zolan
Zolarem
Zoldac
Zoldax
Zopax
Zopic
Zotran

US Patents and Regulatory Information for XANAX XR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn XANAX XR alprazolam TABLET, EXTENDED RELEASE;ORAL 021434-001 Jan 17, 2003 AB RX Yes No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn XANAX XR alprazolam TABLET, EXTENDED RELEASE;ORAL 021434-004 Jan 17, 2003 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn XANAX XR alprazolam TABLET, EXTENDED RELEASE;ORAL 021434-002 Jan 17, 2003 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for XANAX XR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn XANAX XR alprazolam TABLET, EXTENDED RELEASE;ORAL 021434-004 Jan 17, 2003   Start Trial   Start Trial
Pharmacia And Upjohn XANAX XR alprazolam TABLET, EXTENDED RELEASE;ORAL 021434-001 Jan 17, 2003   Start Trial   Start Trial
Pharmacia And Upjohn XANAX XR alprazolam TABLET, EXTENDED RELEASE;ORAL 021434-002 Jan 17, 2003   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Baxter
Johnson and Johnson
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.